Viewing Study NCT02947061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-02-01 @ 7:08 AM
Study NCT ID: NCT02947061
Status: UNKNOWN
Last Update Posted: 2016-10-31
First Post: 2016-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Breast Cancer,first treatment, S1, Capecitabine View